2024 Q2 Form 10-K Financial Statement

#000155479524000164 Filed on July 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2024
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $34.79K $52.89K
YoY Change -14.96% -3122.29%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $34.79K $52.88K $181.2K
YoY Change -14.97% 477.92% -60.4%
Operating Profit -$34.79K -$181.2K
YoY Change -14.97% -60.4%
Interest Expense $8.558K -$15.39K $125.2K
YoY Change -75.11% -57.53% -35.98%
% of Operating Profit
Other Income/Expense, Net -$8.558K $0.00 -$217.7K
YoY Change -93.42% -100.0% -83.16%
Pretax Income -$43.34K -$274.0K -$398.9K
YoY Change -74.65% -74.76% -77.21%
Income Tax
% Of Pretax Income
Net Earnings -$43.34K -$274.0K -$398.9K
YoY Change -74.65% -74.76% -77.21%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 31.98M shares 30.08M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2024 Q1 2024
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.210K $4.300K $4.300K
YoY Change -74.91% -85.12% -85.12%
Cash & Equivalents $7.211K $4.298K $4.300K
Short-Term Investments
Other Short-Term Assets $4.200K $6.500K $6.500K
YoY Change 5.26% -18.55% -18.55%
Inventory
Prepaid Expenses $4.200K $6.500K
Receivables
Other Receivables
Total Short-Term Assets $11.41K $10.80K $10.80K
YoY Change -65.13% -70.72% -70.72%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $11.41K $10.80K $10.80K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $11.41K $10.80K $10.80K
YoY Change -65.13% -70.72% -70.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.000K $0.00
YoY Change -13.21% -100.0%
Accrued Expenses $15.55K $13.03K $13.03K
YoY Change -62.95% -55.67% -55.67%
Deferred Revenue
YoY Change
Short-Term Debt $170.6K $180.4K $180.4K
YoY Change 82.82% 190.92% 190.92%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $217.6K $193.4K $193.4K
YoY Change -37.82% 5.66% 5.66%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $217.6K $193.4K $193.4K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $217.6K $193.4K $193.4K
YoY Change -37.82% 5.66% 5.66%
SHAREHOLDERS EQUITY
Retained Earnings -$17.56M -$17.52M
YoY Change 1.57% 2.33%
Common Stock $31.98K $30.24K
YoY Change 29.49% 22.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$206.1K -$182.6K -$182.6K
YoY Change
Total Liabilities & Shareholders Equity $11.41K $10.80K $10.80K
YoY Change -65.13% -70.72% -70.72%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2024
OPERATING ACTIVITIES
Net Income -$43.34K -$274.0K -$398.9K
YoY Change -74.65% -74.76% -77.21%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$23.49K -$33.30K -$117.1K
YoY Change -6.64% 25.09% -17.55%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $26.40K 25.00K $92.50K
YoY Change 5.6% -16.67% -38.33%
NET CHANGE
Cash From Operating Activities -$23.49K -33.30K -$117.1K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities $26.40K 25.00K $92.50K
Net Change In Cash $2.913K -8.300K -$24.60K
YoY Change -1943.67% -345.56% -408.26%
FREE CASH FLOW
Cash From Operating Activities -$23.49K -$33.30K -$117.1K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001570937
CY2024 dei Amendment Flag
AmendmentFlag
false
CY2024 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2024Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
usd
CY2024Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
usd
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q1 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
shares
CY2024 us-gaap Exploration Expense
ExplorationExpense
usd
CY2023 ATAO Gain Loss On Conversion Of Debt1
GainLossOnConversionOfDebt1
usd
CY2024 us-gaap Debtor Reorganization Items Gain Loss On Settlement Of Other Claims Net1
DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1
usd
CY2024 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
CY2024 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2024 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2024 ATAO Stock Issued Accounts Payable During Period Value Other
StockIssuedAccountsPayableDuringPeriodValueOther
usd
CY2023 ATAO Stock Issued Accrued Compensation During Period Value Other
StockIssuedAccruedCompensationDuringPeriodValueOther
usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17515410 usd
CY2024Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
usd
CY2024Q1 us-gaap Share Price
SharePrice
CY2024 ATAO Conversion Price Maximum
ConversionPriceMaximum
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
pure
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
pure
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2024 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2024Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2023Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2024 dei Document Type
DocumentType
10-K
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024 dei Document Transition Report
DocumentTransitionReport
false
CY2024 dei Entity File Number
EntityFileNumber
333-190235
CY2024 dei Entity Registrant Name
EntityRegistrantName
ALTAIR INTERNATIONAL CORP.
CY2024 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
99-0385465
CY2024 dei Entity Address Address Line1
EntityAddressAddressLine1
322 North Shore Drive
CY2024 dei Entity Address Address Line2
EntityAddressAddressLine2
Building 1B, Suite 200
CY2024 dei Entity Address City Or Town
EntityAddressCityOrTown
Pittsburgh
CY2024 dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
CY2024 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
15212
CY2024 dei City Area Code
CityAreaCode
412
CY2024 dei Local Phone Number
LocalPhoneNumber
770-3140
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Public Float
EntityPublicFloat
8024044 usd
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31975852 shares
CY2024 dei Auditor Name
AuditorName
Fruci & Associates II, PLLC
CY2024 dei Auditor Firm
AuditorFirmId
5525
CY2024 dei Auditor Location
AuditorLocation
Spokane, Washington
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4298 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28897 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
6500 usd
CY2023Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
7980 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
10798 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
36877 usd
CY2024Q1 us-gaap Assets
Assets
10798 usd
CY2023Q1 us-gaap Assets
Assets
36877 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3500 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
25500 usd
CY2024Q1 us-gaap Loans Payable Current
LoansPayableCurrent
14165 usd
CY2023Q1 us-gaap Loans Payable Current
LoansPayableCurrent
14165 usd
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
13029 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
3889 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
5210 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
91100 usd
CY2024Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
166234 usd
CY2023Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
47844 usd
CY2023Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
88169 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
193428 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
183067 usd
CY2024Q1 us-gaap Liabilities
Liabilities
193428 usd
CY2023Q1 us-gaap Liabilities
Liabilities
183067 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30238686 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30238686 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24692459 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24692459 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
30239 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
24693 usd
CY2024Q1 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
58938 shares
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17243603 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
16945642 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17515410 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17116525 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-182630 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-146190 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10798 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
36877 usd
CY2023 us-gaap Exploration Expense
ExplorationExpense
10890 usd
CY2024 us-gaap Labor And Related Expense
LaborAndRelatedExpense
48000 usd
CY2023 us-gaap Labor And Related Expense
LaborAndRelatedExpense
318000 usd
CY2024 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
33600 usd
CY2023 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
32500 usd
CY2024 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
99578 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
96150 usd
CY2024 us-gaap Operating Expenses
OperatingExpenses
181178 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
457540 usd
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
-181178 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-457540 usd
CY2024 us-gaap Interest Expense
InterestExpense
125169 usd
CY2023 us-gaap Interest Expense
InterestExpense
195528 usd
CY2024 ATAO Gain Loss On Conversion Of Debt
GainLossOnConversionOfDebt
4002 usd
CY2023 ATAO Gain Loss On Conversion Of Debt
GainLossOnConversionOfDebt
38444 usd
CY2024 ATAO Change In Fair Value Other Expense
ChangeInFairValueOtherExpense
120069 usd
CY2023 ATAO Change In Fair Value Other Expense
ChangeInFairValueOtherExpense
-1003598 usd
CY2024 us-gaap Nondebtor Reorganization Items Net Gain Loss On Settlement Of Other Claims1
NondebtorReorganizationItemsNetGainLossOnSettlementOfOtherClaims1
-205737 usd
CY2023 us-gaap Nondebtor Reorganization Items Net Gain Loss On Settlement Of Other Claims1
NondebtorReorganizationItemsNetGainLossOnSettlementOfOtherClaims1
6000 usd
CY2024 ATAO Loss On Issuance Of Convertible Debt
LossOnIssuanceOfConvertibleDebt
10872 usd
CY2023 ATAO Loss On Issuance Of Convertible Debt
LossOnIssuanceOfConvertibleDebt
138127 usd
CY2024 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-217707 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1292809 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-398885 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-1750349 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-398885 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1750349 usd
CY2024 ATAO Earnings Per Share Basic And Diluted Atao
EarningsPerShareBasicAndDilutedATAO
-0.02
CY2023 ATAO Earnings Per Share Basic And Diluted Atao
EarningsPerShareBasicAndDilutedATAO
-0.07
CY2024 ATAO Weighted Average Number Of Shares Outstanding Basic And Diluted Atao
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedATAO
25605919 shares
CY2023 ATAO Weighted Average Number Of Shares Outstanding Basic And Diluted Atao
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedATAO
24234937 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
15451 usd
CY2023 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1566208 usd
CY2023 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
70000 shares
CY2023 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
22500 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1750349 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-146190 usd
CY2024 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
270845 usd
CY2024 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
3126668 shares
CY2024 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
86600 usd
CY2024 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
5000 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-398885 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-182630 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-398885 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1750349 usd
CY2024 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
110920 usd
CY2023 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
184389 usd
CY2024 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
3600 usd
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
270000 usd
CY2024 ATAO Gain Loss On Conversion Of Debt
GainLossOnConversionOfDebt
4002 usd
CY2023 ATAO Gain Loss On Conversion Of Debt
GainLossOnConversionOfDebt
38444 usd
CY2024 ATAO Gain Loss On Conversion Of Debt1
GainLossOnConversionOfDebt1
205737 usd
CY2024 ATAO Gain Loss On Issuance Of Convertible Debt
GainLossOnIssuanceOfConvertibleDebt
10872 usd
CY2023 ATAO Gain Loss On Issuance Of Convertible Debt
GainLossOnIssuanceOfConvertibleDebt
138127 usd
CY2023 us-gaap Debtor Reorganization Items Gain Loss On Settlement Of Other Claims Net1
DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1
-6000 usd
CY2024 us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
120069 usd
CY2023 us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
-1003598 usd
CY2024 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
7980 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-7980 usd
CY2024 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3500 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-12000 usd
CY2024 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
56000 usd
CY2023 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
41500 usd
CY2024 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-14248 usd
CY2023 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-11139 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-117099 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-142020 usd
CY2024 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
92500 usd
CY2023 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
100000 usd
CY2023 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
50000 usd
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
92500 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
150000 usd
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-24599 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7980 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28897 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20917 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4298 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28897 usd
CY2024 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
65108 usd
CY2023 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
247364 usd
CY2023 ATAO Stock Issued Accounts Payable During Period Value Other
StockIssuedAccountsPayableDuringPeriodValueOther
22500 usd
CY2024 ATAO Stock Issued Accrued Compensation During Period Value Other
StockIssuedAccruedCompensationDuringPeriodValueOther
76500 usd
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84B_eus-gaap--UseOfEstimates_zjQDY3y1Gg0h" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_86C_z9Lmz0EQIqrb">Use of estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates.</p>
CY2024 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zFdx7P3C09x7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span style="text-decoration: underline"><span id="xdx_868_zozMeX44acOe">Concentrations of Credit Risk</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. We believe we are not exposed to any significant credit risk on cash.</p>
CY2024 ATAO Note Holder
NoteHolder
EROP Enterprises (2)
CY2023Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
88169 usd
CY2024 us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
35872 usd
CY2024 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-3972 usd
CY2024 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
86921 usd
CY2024 ATAO Eliminate Derivate For Change Of Conversion Feature
EliminateDerivateForChangeOfConversionFeature
-206990 usd
CY2022Q4 us-gaap Share Price
SharePrice
0.051
CY2023 ATAO Conversion Price Minimum
ConversionPriceMinimum
0.015
CY2023 ATAO Conversion Price Maximum
ConversionPriceMaximum
0.056
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.8753 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
2.0008 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0464 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0494 pure
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y1M17D
CY2023 ATAO Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2
P0Y11M26D
CY2023Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 25 reverse stock split and reduced its authorized shares of common stock from 5,000,000,000 (5 billion) to
CY2023Q1 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
500000000 shares
CY2024 ATAO Common Stock Reclassed To Additional Paid In Capital
CommonStockReclassedToAdditionalPaidInCapital
592619 usd
CY2021Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
40000 shares
CY2024Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.25
CY2024 ATAO Aggregate Fair Value Of Warrants
AggregateFairValueOfWarrants
180000 usd
CY2024Q1 ATAO Warrants Estimates Used Stock Price
WarrantsEstimatesUsedStockPrice
4.50
CY2024 ATAO Warrants Estimates Used Exercise Price
WarrantsEstimatesUsedExercisePrice
0.25
CY2024 ATAO Warrants Estimates Used Risk Free Rate
WarrantsEstimatesUsedRiskFreeRate
0.0157 pure
CY2024 ATAO Warrants Estimates Used Volatility
WarrantsEstimatesUsedVolatility
7.3546 pure
us-gaap Officers Compensation
OfficersCompensation
22000 usd
CY2023 us-gaap Officers Compensation
OfficersCompensation
34000 usd
CY2024Q1 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
0 usd
CY2023Q1 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
18000 usd
CY2022 ATAO Stock Issued During Period Shares Related Parties2
StockIssuedDuringPeriodSharesRelatedParties2
400000 shares
CY2022 ATAO Stock Issued During Period Price Per Share Related Parties2
StockIssuedDuringPeriodPricePerShareRelatedParties2
0.90
CY2022 ATAO Stock Issued Related Party Non Cash Stock Compensation Expense2
StockIssuedRelatedPartyNonCashStockCompensationExpense2
360000 usd
CY2023 ATAO Conversion Of Payables Into Common Stock Amount
ConversionOfPayablesIntoCommonStockAmount
22500 usd
CY2023 ATAO Conversion Of Payables Into Common Stock Shares
ConversionOfPayablesIntoCommonStockShares
70000 shares
CY2024 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
5000 usd
CY2024Q1 ATAO Amounts Owed To Related Party For Director Fees
AmountsOwedToRelatedPartyForDirectorFees
0 usd
CY2023Q1 ATAO Amounts Owed To Related Party For Director Fees
AmountsOwedToRelatedPartyForDirectorFees
7500 usd
CY2024 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
83800 usd
CY2023 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
367600 usd
CY2024 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
83800 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
367600 usd
CY2024Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3678000 usd
CY2023Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3594000 usd
CY2024Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3678000 usd
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3594000 usd
CY2024Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
3678000 usd

Files In Submission

Name View Source Status
0001554795-24-000164-index-headers.html Edgar Link pending
0001554795-24-000164-index.html Edgar Link pending
0001554795-24-000164.txt Edgar Link pending
0001554795-24-000164-xbrl.zip Edgar Link pending
atao-20240331.xsd Edgar Link pending
atao0618form10k.htm Edgar Link pending
atao0628form10kexh31_1.htm Edgar Link pending
atao0628form10kexh32_1.htm Edgar Link pending
auditorheader.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
atao-20240331_cal.xml Edgar Link unprocessable
atao-20240331_def.xml Edgar Link unprocessable
atao-20240331_lab.xml Edgar Link unprocessable
atao-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
atao0618form10k_htm.xml Edgar Link completed
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending